This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Ruth Milz: Innovator in Pharmaceutical Formulations
Introduction
Ruth Milz is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. With a total of 3 patents to her name, her work has had a substantial impact on patient treatment options.
Latest Patents
Ruth Milz's latest patents focus on dosing regimens associated with extended-release paliperidone injectable formulations. One of her notable inventions provides methods for treating patients with long-acting injectable paliperidone palmitate formulations. This invention includes methods for mitigating adverse changes in blood lipid levels in patients treated with paliperidone palmitate extended-release injectable suspension at one-month or three-month intervals. Additionally, she has developed a method for transitioning patients to a six-month dosing interval for improved treatment outcomes.
Career Highlights
Ruth Milz has established herself as a key figure in the pharmaceutical industry. Her innovative approaches to drug formulation have led to advancements in patient care and treatment efficacy. She is currently associated with Janssen Pharmaceutica NV, where she continues to contribute to groundbreaking research and development.
Collaborations
Ruth has collaborated with several talented individuals in her field, including Panna Sanga and John Louie. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Ruth Milz is a remarkable inventor whose work in pharmaceutical formulations is paving the way for improved patient care. Her contributions are vital to the ongoing advancements in the field, and her patents reflect her commitment to innovation.